title: From Regulatory Approval to Subsidised Patient Access in the Asia-Pacific Region: A Comparison of Systems Across Australia, China, Japan, Korea, New Zealand, Taiwan And Thailand.
authors.affiliation: Bristol-Myers Squibb, Melbourne, Australia.
authors.forename: H
authors.initials: H
authors.lastname: Kim
authors.affiliation: Bristol-Myers Squibb, Seoul, South Korea.
authors.forename: H
authors.initials: H
authors.lastname: Jung
authors.affiliation: Bristol-Myers Squibb, Taipei, Taiwan.
authors.forename: P
authors.initials: P
authors.lastname: Chou
authors.affiliation: Bristol-Myers Squibb, Tokyo, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Kunihara
authors.affiliation: Bristol-Myers Squibb, Bangkok, Thailand.
authors.forename: J
authors.initials: J
authors.lastname: Tosanguan
authors.affiliation: Bristol-Myers Squibb, Shanghai, China.
authors.forename: Z
authors.initials: Z
authors.lastname: Tang
authors.affiliation: Bristol-Myers Squibb, Melbourne, Australia.
authors.forename: S
authors.initials: S
authors.lastname: Brydon
authors.affiliation: Bristol-Myers Squibb, Melbourne, Australia.
authors.forename: G
authors.initials: G
authors.lastname: Cook